IRIS
LIGUORI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.238
AS - Asia 4.121
EU - Europa 2.627
SA - Sud America 704
AF - Africa 71
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 33.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.120
SG - Singapore 2.469
CN - Cina 629
BR - Brasile 605
IT - Italia 590
HK - Hong Kong 398
IE - Irlanda 385
DE - Germania 324
UA - Ucraina 269
RU - Federazione Russa 235
GB - Regno Unito 202
KR - Corea 175
VN - Vietnam 174
FR - Francia 123
FI - Finlandia 97
SE - Svezia 93
PL - Polonia 84
NL - Olanda 76
CA - Canada 73
IN - India 52
AR - Argentina 47
ID - Indonesia 47
JP - Giappone 39
AT - Austria 36
MX - Messico 34
CZ - Repubblica Ceca 26
BD - Bangladesh 22
ZA - Sudafrica 22
BE - Belgio 19
ES - Italia 19
TR - Turchia 16
EG - Egitto 15
CL - Cile 11
IQ - Iraq 11
MA - Marocco 10
AU - Australia 9
CH - Svizzera 9
PY - Paraguay 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
GR - Grecia 8
DK - Danimarca 7
EC - Ecuador 7
EU - Europa 7
KZ - Kazakistan 6
MY - Malesia 6
PH - Filippine 6
SA - Arabia Saudita 6
TN - Tunisia 6
VE - Venezuela 6
AZ - Azerbaigian 5
KE - Kenya 5
LT - Lituania 5
PE - Perù 5
PK - Pakistan 5
TW - Taiwan 5
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
NP - Nepal 4
RO - Romania 4
AM - Armenia 3
BO - Bolivia 3
JO - Giordania 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
BG - Bulgaria 2
GE - Georgia 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
MK - Macedonia 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 33.777
Salva come PNG Salva come JPEG
Città #
Wilmington 6.711
Houston 6.266
Woodbridge 5.844
Fairfield 1.059
Singapore 850
Ashburn 701
Chandler 571
Seattle 440
Cambridge 406
Ann Arbor 399
Hong Kong 394
Dublin 341
Beijing 326
Medford 255
Rome 219
New York 198
Santa Clara 197
Jacksonville 196
Los Angeles 134
Lawrence 122
The Dalles 116
Dearborn 115
Buffalo 84
San Diego 79
Council Bluffs 74
Menlo Park 74
São Paulo 67
Munich 63
Ho Chi Minh City 58
Kraków 56
Dallas 55
Milan 49
Zhengzhou 49
London 48
Moscow 47
Boardman 42
Norwalk 42
Hanoi 38
Jakarta 36
Redwood City 36
Seoul 31
Shanghai 31
Chicago 30
Toronto 29
Helsinki 27
Nuremberg 26
Stockholm 26
Tokyo 26
Atlanta 25
Phoenix 25
Boston 24
Brno 24
Brooklyn 23
Warsaw 23
Amsterdam 21
Redondo Beach 21
Guangzhou 20
Chennai 19
Durham 19
Montreal 18
Nanjing 18
Salt Lake City 18
Brussels 17
Rio de Janeiro 17
Daejeon 16
Denver 16
Monte Porzio Catone 16
Orem 16
Philadelphia 16
Vienna 16
Belo Horizonte 15
Kilburn 15
Lappeenranta 15
San Jose 15
Columbus 14
Verona 14
Washington 14
Johannesburg 13
Manchester 13
Mexico City 13
Poplar 13
Porto Alegre 13
Bologna 12
Palo Alto 12
Pune 12
Brasília 11
Istanbul 11
Mountain View 10
San Francisco 10
University Park 10
Biên Hòa 9
Cairo 9
Florence 9
Naples 9
Frankfurt am Main 8
Tampa 8
Athens 7
Creede 7
Curitiba 7
Guarulhos 7
Totale 27.846
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 604
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 565
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 528
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 489
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 479
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 464
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 464
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 464
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 463
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 454
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 452
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 450
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 445
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 437
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 435
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 434
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 433
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 431
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 428
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 427
May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis 424
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 424
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 419
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 419
null 419
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 418
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 413
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 413
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 405
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 403
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 402
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 401
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 396
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 394
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 392
Catecholamine-based treatment in AD patients: expectations and delusions 392
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 386
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 374
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 370
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 369
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 366
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 366
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 365
Restless legs syndrome and post polio syndrome: a case-control study 364
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 364
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 357
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 355
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 353
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 351
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 348
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 347
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report 344
Obstructive sleep apnoea and bone health 342
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 341
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 328
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 326
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease 321
Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity 318
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 297
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 294
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 280
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 276
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study 261
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 259
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 252
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 231
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 230
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 226
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 222
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 220
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 218
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 218
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 217
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 189
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 176
Seasonality of restless legs syndrome: symptom variability in winter and summer times 176
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 169
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 165
Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment 163
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 159
Laterality of Auditory Dysfunction in Parkinson's Disease 155
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 153
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 149
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 145
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease 132
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 127
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 123
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 119
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 117
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 115
Acute care hospital at different levels of intensity: the role of Geriatrician 110
The Italian version of the “frailty index” based on deficits in health: a validation study 109
Sarcopenia: Assessment of disease burden and strategies to improve outcomes 109
Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure 109
Increased noradrenaline as an additional cerebrospinal fluid biomarker in PSP-like parkinsonism 105
Is it time to consider obstructive sleep apnea syndrome a risk factor for Alzheimer's disease? 105
Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: a cerebrospinal fluid-based study 104
The reverse metabolic syndrome in the elderly: Is it a “catabolic” syndrome? 103
Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: A prospective study 99
Physical Activity Scale for the Elderly (PASE) Score Is Related to Sarcopenia in Noninstitutionalized Older Adults 93
Totale 30.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.319 0 0 0 0 0 605 633 484 103 205 207 82
2021/20221.436 67 90 64 35 28 72 241 42 75 110 98 514
2022/20231.570 190 137 56 164 145 350 138 109 138 28 68 47
2023/2024745 77 15 43 26 70 211 39 108 15 21 8 112
2024/20254.384 140 697 353 197 113 520 184 190 364 321 746 559
2025/20262.931 535 284 777 674 597 64 0 0 0 0 0 0
Totale 34.416